ARL

Arvind Remedies Limited has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the Shareholders of the company to be held on September 29, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)<a href=/content/corporate/ArvindRem_NotAGM_08092008.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that the Annual General Meeting of the Company will be held on September 29, 2008. The Register of Members and the share transfer books of the Company will remain closed from September 25, 2008 to September 29, 2008 (both days inclusive) for the purpose of AGM and dividend.

Arvind Remedies Limited has informed the Exchange that : "Mrs. Susan Sujatha Lyall has resigned from our service as Company Secretary, and our new Company Secretary is Mr. V. Viswanathan".

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on June 30, 2008 have recommended a dividend of 5% subject to approval of the members.

Arvind Remedies Limited has informed the Exchange that the company has decided to publish the audited result for the financial year ended March 31, 2008 on or before June 30, 2008 instead of publishing the last and fourth quarter unaudited financial results by April 30, 2008.

Arvind Remedies Limited has submitted to the Exchange a copy of revised Shareholding Pattern under Clause 35 of the Listing Agreement for the quarter ended December 31, 2007. The Company has informed the Exchange that "331 shareholders holding 3195150 equity shares in our Company and appearing as "Others" under the category Public Shareholding-Non-institutional- Any Others should have appeared as follows: (1) One shareholder (out of the above 331) holding 3150 equity shares in our company is of the Non-institutions-Body Corporate Category. (2) 329 shareholders (out of the above 331) holdin

Arvind Remedies Limited has informed the Exchange that the auditor's have conducted the limited review of the Un-Audited Financial Results for the quarter and nine months ended December 31, 2007 and found the same to be in order subject to certain observations. The auditor's observation are "Revised Accounting Standard 15- 'Employee Benefits', issued by The Institute of Chartered Accountants of India has become applicable to the company with effect from 1st April' 2007. The impact of such revision, presently not ascertained, will be considered at the year end."

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on January 31, 2008 have decided to set up a new Manufacturing Unit, at par with the international standards, in the State of Uttarakhand.

Arvind Remedies Limited has informed the Exchange that Due to unavoidable reasons Company is withdrawing the earlier intimation regarding the Meeting of the Board of Directors of the Company to be held on December 31, 2007.

Arvind Remedies Limited has informed the Exchange that the auditor's have conducted the limited review of the Un-Audited Financial Results for the quarter ended September 30, 2007 and found the same to be in order subject to certain observations. The auditor's observation are "Revised Accounting Standard 15- 'Employee Benefits', issued by The Institute of Chartered Accountants of India has become applicable to the company with effect from 1st April' 2007. The impact of such revision, presently not ascertained, will be considered at the year end."

Arvind Remedies Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the members of the Company held on September 28, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ArvindRemedies_AGMProceedings.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange vide its letter dated September 27, 2007 that "Shri K.V. Viswanathan, Company Secretary of Arvind Remedies Limited, has resigned from the post of Company Secretary with effect from 09.09.2007. Mrs. Susan Sujatha Lyall, ACS, Membership No. 18134, has joined the Company as Company Secretary with effect from 10.09.2007".

Arvind Remedies Limited has informed the Exchange that the Annual General Meeting of the Company will be held on September 28, 2007. Further, the Register of Members and the share transfer books of the Company will remain closed from September 25, 2007 to September 28, 2007 (both days inclusive) for the purpose of AGM and dividend.

Arvind Remedies Limited has informed the Exchange that: "Mr. K. Hari Prasath has resigned from our service as Company Secretary, and our new Company Secretary is Mr. K.V. Viswanathan, who has taken charge with effect from 29.06.2007".

Arvind Remedies Limited has informed the Exchange that the Board of Directors, at their meeting held on June 29, 2007 have recommended a dividend of 5% subject to the approval of members.

Arvind Remedies Limited has informed the Exchange that the Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.

Arvind Remedies Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the members of the Company held on September 25, 2006. The copy of minutes shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).<a href=/content/corporate/arvind_nse_260906.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that the AGM of the Company will be held on September 25, 2006. The Register of Members and the share transfer books of the Company will remain closed from September 21, 2006 to September 25, 2006 (both days inclusive) for the purpose of AGM and Dividend.

Arvind Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on June 28,2006 have recommended a dividend of 5% subject to the approval of members.

Arvind Remedies Limited has informed the Exchange that Arvind Remedies Limited has entered into agreement with Sri Ramachandra Medical College & Research Institute (Deemed University), Chennai and Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, for project in research and development of Ayurvedic Herbal Medicine for Rheumatoid Arthritis. The total project cost is estimated around Rs. 1.03 crore.

Arvind Remedies Limited has informed the Exchange that EGM of the Company was held on March 27, 2006 for the purpose of considering the issue / allotment of equity shares / convertible warrants on preferential basis. In that meeting it was decided to drop the special businesses of issue / allotment of equity shares / convertible warrants on preferential basis.

Arvind Remedies Limited has submitted to the Exchange a copy of the Notice of the EGM of the Company to be held on March 27, 2006, to consider the allotment of shares / warrants on preferential basis. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Arvind Remedies Limited has informed the Exchange that the Board of Directors in their meeting held on March 09, 2006 had decided to set up a new manufacturing unit at Haridwar, in the State of Uttaranchal, at par with the international standards.

Arvind Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on February 27, 2006 had considered and approved the following :- (a) To increase the paid up capital by issue and allot 1,34,00,000 Equity Shares of Re.1/- each at a price of Rs.2.40 (Including premium) to Dr. B. Arvind Shah. (b) To issue and allot 1,40,90,000 warrants to Dr. B. Arvind Shah having rights to convert upto 1,40,90,000/- equity shares of Re.1/- each at a price of Rs.2.40 (including premium). (c) To hold an EGM of the shareholders on March 27, 2006 to get the shareholder's approval

Arvind Remedies Limited has informed the Exchange that Shareholder has approved 2% dividend, as recommended by the BODs and same will be paid as soon as all the formalities are completed. Further, the Company has submitted a copy of the Minutes of the AGM of the Company held on September 26, 2005. The details of the Minutes shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Arvind Remedies Limited has informed the Exchange that in the AGM held on September 26, 2005 the shareholders have given approval to delist the equity shares of the Company from the Madras Stock Exchange and The Stock Exchange, Ahmedabad.

Arvind Remedies Limited has informed the Exchange that the AGM of the Company will be held on September 26, 2005. The Register of Members and the share transfer books of the Company will remain closed from September 22, 2005 to September 26, 2005 (both days inclusive) for the purpose of AGM and Dividend.

Arvind Remedies Limited has informed the Exchange that Mr. K.Hari Prasath, Company Secretary of the Company has been appointed as the Compliance Officer of the Company w.e.f. June 27, 2005.

Arvind Remedies Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on June 28, 2005 recommendation of a final dividend of 2% for the year 2004-05, subject to the approval of members was considered and approved.

Clarification of News : The press had reports on March 11, 2004 that Citiconsult Emerging Markets, a UK based financial institution, will invest $10m in Arvind Remedies Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Arvind Remedies Limited has vide its letter interalia stated, "We wish to inform you that the investment proposal referred to in the press is in the negotiation stage from the last quarter